$7.83 Billion is the total value of Eventide Asset Management's 146 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 23.7% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
ASND | ASCENDIS PHARMA A/Ssponsored adr | $235,246,000 | -15.6% | 1,748,648 | 0.0% | 3.01% | -18.2% | |
BHVN | Buy | BIOHAVEN PHARMACTL HLDG CO L | $225,319,000 | +22.4% | 1,635,000 | +23.4% | 2.88% | +18.6% |
MTD | METTLER TOLEDO INTERNATIONAL | $214,697,000 | +23.2% | 126,500 | 0.0% | 2.74% | +19.4% | |
FIVN | Sell | FIVE9 INC | $200,899,000 | -14.4% | 1,463,000 | -0.4% | 2.57% | -17.0% |
TTD | Sell | THE TRADE DESK INC | $200,646,000 | +3.5% | 2,189,500 | -20.6% | 2.56% | +0.4% |
IDXX | IDEXX LABS INC | $185,488,000 | +5.9% | 281,700 | 0.0% | 2.37% | +2.6% | |
DT | Buy | DYNATRACE INC | $165,458,000 | -14.8% | 2,741,641 | +0.1% | 2.11% | -17.5% |
ODFL | OLD DOMINION FREIGHT LINE IN | $159,551,000 | +25.3% | 445,200 | 0.0% | 2.04% | +21.4% | |
HUBS | Buy | HUBSPOT INC | $158,613,000 | -1.4% | 240,633 | +1.1% | 2.03% | -4.4% |
DLO | Buy | DLOCAL LTD | $156,655,000 | +468.5% | 4,389,312 | +769.1% | 2.00% | +451.5% |
ROP | ROPER TECHNOLOGIES INC | $153,657,000 | +10.3% | 312,400 | 0.0% | 1.96% | +6.8% | |
TT | Buy | TRANE TECHNOLOGIES PLC | $148,128,000 | +34.1% | 733,200 | +14.6% | 1.89% | +29.9% |
RXDX | Buy | PROMETHEUS BIOSCIENCES INC | $145,120,000 | +70.5% | 3,742,507 | +0.8% | 1.85% | +65.1% |
ARGX | Buy | ARGENX SEsponsored adr | $144,453,000 | +43.6% | 412,500 | +23.9% | 1.85% | +39.2% |
NEP | Buy | NEXTERA ENERGY PARTNERS LP | $140,492,000 | +21.7% | 1,664,600 | +8.7% | 1.80% | +17.9% |
POOL | Sell | POOL CORP | $139,859,000 | +27.9% | 247,100 | -1.9% | 1.79% | +23.9% |
GLBE | Buy | GLOBAL E ONLINE LTD | $135,647,000 | +295.1% | 2,139,886 | +347.5% | 1.73% | +282.6% |
TREX | Buy | TREX CO INC | $133,680,000 | +48.7% | 990,000 | +12.2% | 1.71% | +44.0% |
ZI | Sell | ZOOMINFO TECHNOLOGIES INC | $133,279,000 | +2.7% | 2,076,000 | -2.1% | 1.70% | -0.5% |
LOW | Buy | LOWES COS INC | $132,109,000 | +28.3% | 511,100 | +0.7% | 1.69% | +24.3% |
LRCX | Sell | LAM RESEARCH CORP | $129,696,000 | +11.5% | 180,346 | -11.8% | 1.66% | +8.0% |
GNRC | Buy | GENERAC HLDGS INC | $129,542,000 | +0.4% | 368,100 | +16.6% | 1.66% | -2.8% |
CTAS | CINTAS CORP | $128,342,000 | +16.4% | 289,600 | 0.0% | 1.64% | +12.8% | |
CRWD | Sell | CROWDSTRIKE HLDGS INCcl a | $125,942,000 | -35.4% | 615,100 | -22.5% | 1.61% | -37.4% |
ASML | Sell | ASML HOLDING N V | $122,844,000 | -4.1% | 154,300 | -10.3% | 1.57% | -7.1% |
DHI | Buy | D R HORTON INC | $116,215,000 | +31.1% | 1,071,600 | +1.5% | 1.48% | +27.0% |
EXAS | EXACT SCIENCES CORP | $115,967,000 | -18.5% | 1,490,000 | 0.0% | 1.48% | -21.0% | |
WCN | WASTE CONNECTIONS INC | $109,561,000 | +8.2% | 804,000 | 0.0% | 1.40% | +4.9% | |
ENTG | Buy | ENTEGRIS INC | $99,708,000 | +11.5% | 719,500 | +1.3% | 1.27% | +8.1% |
KRTX | KARUNA THERAPEUTICS INC | $97,988,000 | +7.1% | 748,000 | 0.0% | 1.25% | +3.7% | |
SPT | Buy | SPROUT SOCIAL INC | $90,322,000 | -25.6% | 995,943 | +0.0% | 1.15% | -28.0% |
GH | Buy | GUARDANT HEALTH INC | $88,628,000 | +298.3% | 886,100 | +397.8% | 1.13% | +286.7% |
APTV | APTIV PLC | $88,578,000 | +10.7% | 537,000 | 0.0% | 1.13% | +7.3% | |
DDOG | Buy | DATADOG INC | $87,096,000 | +27.0% | 489,000 | +0.8% | 1.11% | +23.1% |
PANW | PALO ALTO NETWORKS INC | $84,620,000 | +16.2% | 151,987 | 0.0% | 1.08% | +12.6% | |
BCYC | Buy | BICYCLE THERAPEUTICS PLCsponsored ads | $76,907,000 | +58.9% | 1,263,471 | +8.6% | 0.98% | +54.1% |
PRAX | PRAXIS PRECISION MEDICINES I | $75,069,000 | +6.5% | 3,810,599 | 0.0% | 0.96% | +3.2% | |
CCI | Buy | CROWN CASTLE INTL CORP NEW | $69,552,000 | +22.5% | 333,200 | +1.7% | 0.89% | +18.7% |
YETI | Buy | YETI HLDGS INC | $66,504,000 | +12.5% | 802,900 | +16.4% | 0.85% | +9.0% |
KNBE | New | KNOWBE4 INCcl a | $66,205,000 | – | 2,886,000 | +100.0% | 0.85% | – |
W | WAYFAIR INCcl a | $63,541,000 | -25.6% | 334,477 | 0.0% | 0.81% | -28.0% | |
MGA | Sell | MAGNA INTL INC | $61,871,000 | +5.4% | 764,400 | -2.0% | 0.79% | +2.2% |
A | Buy | AGILENT TECHNOLOGIES INC | $60,076,000 | +18.3% | 376,300 | +16.8% | 0.77% | +14.6% |
HASI | Buy | HANNON ARMSTRONG SUST INFR C | $56,902,000 | +10.4% | 1,071,200 | +11.1% | 0.73% | +6.9% |
NRIX | Buy | NURIX THERAPEUTICS INC | $54,137,000 | +50.6% | 1,870,000 | +55.8% | 0.69% | +46.0% |
CWEN | Buy | CLEARWAY ENERGY INCcl c | $53,440,000 | +25.9% | 1,483,200 | +5.7% | 0.68% | +22.0% |
VITL | VITAL FARMS INC | $53,277,000 | +2.8% | 2,950,000 | 0.0% | 0.68% | -0.3% | |
SMAR | Buy | SMARTSHEET INC | $52,511,000 | +14.9% | 678,000 | +2.1% | 0.67% | +11.3% |
NOVT | NOVANTA INC | $49,372,000 | +14.1% | 280,000 | 0.0% | 0.63% | +10.7% | |
TSM | Sell | TAIWAN SEMICONDUCTOR MFG LTDsponsored ads | $49,327,000 | -2.5% | 410,000 | -9.5% | 0.63% | -5.5% |
COLL | COLLEGIUM PHARMACEUTICAL INC | $49,121,000 | -5.4% | 2,629,593 | 0.0% | 0.63% | -8.2% | |
XMTR | Buy | XOMETRY INC | $48,894,000 | +14.1% | 954,030 | +28.4% | 0.62% | +10.6% |
VRSK | VERISK ANALYTICS INC | $48,719,000 | +14.2% | 213,000 | 0.0% | 0.62% | +10.7% | |
CLDX | Buy | CELLDEX THERAPEUTICS INC NEW | $47,871,000 | -21.4% | 1,238,900 | +9.8% | 0.61% | -23.8% |
MDB | MONGODB INCcl a | $47,300,000 | +12.3% | 89,355 | 0.0% | 0.60% | +8.6% | |
EPIX | Buy | ESSA PHARMA INC | $47,125,000 | +170.1% | 3,318,647 | +52.2% | 0.60% | +161.7% |
ZYME | Sell | ZYMEWORKS INC | $46,206,000 | -57.3% | 2,819,135 | -24.4% | 0.59% | -58.7% |
DICE THERAPEUTICS INC | $45,761,000 | -22.7% | 1,871,612 | 0.0% | 0.58% | -25.1% | ||
SHLS | Sell | SHOALS TECHNOLOGIES GROUP INcl a | $44,880,000 | -15.5% | 1,846,900 | -3.1% | 0.57% | -18.1% |
ZNTL | ZENTALIS PHARMACEUTICALS INC | $44,468,000 | +26.1% | 529,000 | 0.0% | 0.57% | +22.2% | |
BEP | BROOKFIELD RENEWABLE PARTNERpartnership unit | $44,236,000 | -3.0% | 1,236,000 | 0.0% | 0.56% | -6.1% | |
MRTX | Buy | MIRATI THERAPEUTICS INC | $42,779,000 | +86.8% | 291,626 | +125.2% | 0.55% | +81.1% |
COUR | Buy | COURSERA INC | $42,482,000 | +67.8% | 1,738,228 | +117.3% | 0.54% | +62.6% |
BPMC | Buy | BLUEPRINT MEDICINES CORP | $42,394,000 | +15.8% | 395,800 | +11.2% | 0.54% | +12.2% |
IMVT | IMMUNOVANT INC | $42,174,000 | -2.0% | 4,950,000 | 0.0% | 0.54% | -4.9% | |
MPWR | Buy | MONOLITHIC PWR SYS INC | $42,011,000 | +11.9% | 85,157 | +9.9% | 0.54% | +8.5% |
STRO | Buy | SUTRO BIOPHARMA INC | $40,310,000 | -10.0% | 2,708,975 | +14.3% | 0.52% | -12.9% |
ADCT | Buy | ADC THERAPEUTICS SA | $39,895,000 | +12.0% | 1,975,000 | +50.5% | 0.51% | +8.5% |
CCXI | CHEMOCENTRYX INC | $37,866,000 | +112.9% | 1,040,000 | 0.0% | 0.48% | +106.0% | |
NCNO | Buy | NCINO INC | $37,744,000 | -19.8% | 688,000 | +3.8% | 0.48% | -22.4% |
MASS | Buy | 908 DEVICES INC | $36,477,000 | +64.4% | 1,410,000 | +106.7% | 0.47% | +59.0% |
LSCC | Buy | LATTICE SEMICONDUCTOR CORP | $36,353,000 | +862.0% | 471,744 | +707.1% | 0.46% | +830.0% |
ANNX | Buy | ANNEXON INC | $32,747,000 | -30.5% | 2,850,000 | +12.6% | 0.42% | -32.7% |
NVT | Buy | NVENT ELECTRIC PLC | $31,624,000 | +26.7% | 832,200 | +7.8% | 0.40% | +22.8% |
RGEN | REPLIGEN CORP | $31,516,000 | -8.4% | 119,000 | 0.0% | 0.40% | -11.0% | |
COGT | New | COGENT BIOSCIENCES INC | $30,158,000 | – | 3,514,909 | +100.0% | 0.38% | – |
BEPC | Sell | BROOKFIELD RENEWABLE CORPcl a sub vtg | $28,544,000 | -19.7% | 775,019 | -15.4% | 0.36% | -22.2% |
CGNX | COGNEX CORP | $27,916,000 | -3.1% | 359,000 | 0.0% | 0.36% | -6.1% | |
New | DUOLINGO INC | $27,323,000 | – | 257,500 | +100.0% | 0.35% | – | |
PLD | Buy | PROLOGIS INC. | $27,039,000 | +47.2% | 160,600 | +9.6% | 0.35% | +43.0% |
ISRG | Buy | INTUITIVE SURGICAL INC | $26,948,000 | +8.4% | 75,000 | +200.0% | 0.34% | +4.9% |
VCYT | VERACYTE INC | $26,821,000 | -11.3% | 651,000 | 0.0% | 0.34% | -14.0% | |
SNDX | SYNDAX PHARMACEUTICALS INC | $25,502,000 | +14.5% | 1,165,000 | 0.0% | 0.33% | +10.9% | |
KLAC | Sell | KLA CORP | $24,528,000 | +19.4% | 57,028 | -7.1% | 0.31% | +15.5% |
REXR | Buy | REXFORD INDL RLTY INC | $23,958,000 | +125.0% | 295,374 | +57.4% | 0.31% | +118.6% |
PNR | Buy | PENTAIR PLC | $23,866,000 | +37.4% | 326,800 | +36.6% | 0.30% | +33.2% |
CIEN | Sell | CIENA CORP | $23,861,000 | +41.8% | 310,000 | -5.4% | 0.30% | +37.4% |
TALS | TALARIS THERAPEUTICS INC | $23,869,000 | +15.4% | 1,561,092 | 0.0% | 0.30% | +11.7% | |
STE | Sell | STERIS PLC | $23,851,000 | +15.0% | 97,985 | -3.5% | 0.30% | +11.7% |
LOB | Buy | LIVE OAK BANCSHARES INC | $23,230,000 | +41.0% | 266,128 | +2.8% | 0.30% | +36.9% |
ESI | Buy | ELEMENT SOLUTIONS INC | $22,670,000 | +123.4% | 933,700 | +99.5% | 0.29% | +116.4% |
NDAQ | Buy | NASDAQ INC | $22,261,000 | +33.9% | 106,000 | +23.1% | 0.28% | +29.7% |
CGEM | CULLINAN ONCOLOGY INC | $21,665,000 | -31.6% | 1,440,145 | 0.0% | 0.28% | -33.7% | |
XNCR | XENCOR INC | $20,301,000 | +22.8% | 506,000 | 0.0% | 0.26% | +18.8% | |
NBIX | NEUROCRINE BIOSCIENCES INC | $20,015,000 | -11.2% | 235,000 | 0.0% | 0.26% | -13.8% | |
ELS | Buy | EQUITY LIFESTYLE PPTYS INC | $20,004,000 | +30.1% | 228,200 | +16.0% | 0.26% | +26.1% |
GXO LOGISTICS INCORPORATED | $19,983,000 | +15.8% | 220,000 | 0.0% | 0.26% | +11.8% | ||
FRC | Sell | FIRST REP BK SAN FRANCISCO C | $19,598,000 | +3.0% | 94,900 | -3.8% | 0.25% | -0.4% |
KURA | KURA ONCOLOGY INC | $19,055,000 | -25.3% | 1,361,044 | 0.0% | 0.24% | -27.7% | |
SNV | Buy | SYNOVUS FINL CORP | $18,382,000 | +189.3% | 384,000 | +165.2% | 0.24% | +179.8% |
XPO | XPO LOGISTICS INC | $17,035,000 | -2.7% | 220,000 | 0.0% | 0.22% | -5.6% | |
MAX | MEDIAALPHA INCcl a | $16,957,000 | -17.3% | 1,098,246 | 0.0% | 0.22% | -19.9% | |
SNPS | SYNOPSYS INC | $16,861,000 | +23.1% | 45,757 | 0.0% | 0.22% | +18.8% | |
APTVPRA | New | APTIV PLC5.5% cnv pfd a added | $16,098,000 | – | 87,500 | +100.0% | 0.21% | – |
SBNY | Sell | SIGNATURE BK NEW YORK N Y | $15,769,000 | +15.1% | 48,750 | -3.1% | 0.20% | +11.6% |
Sell | PALO ALTO NETWORKS INCnote 0.750% 7/0 | $14,293,000 | -20.3% | 6,810,000 | -30.9% | 0.18% | -22.8% | |
IEX | Buy | IDEX CORP | $13,801,000 | +45.9% | 58,400 | +27.8% | 0.18% | +40.8% |
ENPH | New | ENPHASE ENERGY INC | $12,166,000 | – | 66,500 | +100.0% | 0.16% | – |
AESC | AES CORPunit 99/99/9999 | $11,866,000 | -0.4% | 123,600 | 0.0% | 0.15% | -3.2% | |
VECT | VECTIVBIO HLDG AG | $11,186,000 | -36.4% | 2,339,044 | 0.0% | 0.14% | -38.4% | |
SYY | Buy | SYSCO CORP | $10,321,000 | +45.6% | 131,398 | +45.5% | 0.13% | +41.9% |
COMP | Sell | COMPASS INCcl a | $10,098,000 | -75.2% | 1,110,899 | -63.8% | 0.13% | -75.9% |
CRDF | CARDIFF ONCOLOGY INC | $10,039,000 | -9.8% | 1,670,399 | 0.0% | 0.13% | -12.9% | |
ETNB | Sell | 89BIO INC | $9,367,000 | -58.0% | 716,670 | -37.0% | 0.12% | -59.2% |
DSGN | DESIGN THERAPEUTICS INC | $8,564,000 | +45.7% | 400,000 | 0.0% | 0.11% | +41.6% | |
GRMN | Buy | GARMIN LTD | $8,306,000 | +19.0% | 61,000 | +35.9% | 0.11% | +15.2% |
WMS | ADVANCED DRAIN SYS INC DEL | $7,906,000 | +25.9% | 58,078 | 0.0% | 0.10% | +21.7% | |
WMB | New | WILLIAMS COS INC | $7,523,000 | – | 288,900 | +100.0% | 0.10% | – |
IMGN | New | IMMUNOGEN INC | $7,420,000 | – | 1,000,000 | +100.0% | 0.10% | – |
BOLT | Buy | BOLT BIOTHERAPEUTICS INC | $7,103,000 | +5.2% | 1,449,494 | +171.4% | 0.09% | +2.2% |
EGP | New | EASTGROUP PPTYS INC | $6,881,000 | – | 30,200 | +100.0% | 0.09% | – |
New | ROIVANT SCIENCES LTD | $6,703,000 | – | 700,000 | +100.0% | 0.09% | – | |
FRLN | FREELINE THERAPEUTICS HLDGSsponsored ads | $6,746,000 | -42.7% | 3,485,656 | 0.0% | 0.09% | -44.5% | |
PHAT | Sell | PHATHOM PHARMACEUTICALS INC | $6,614,000 | -65.7% | 336,223 | -44.0% | 0.08% | -66.5% |
LNG | New | CHENIERE ENERGY INC | $6,684,000 | – | 65,900 | +100.0% | 0.08% | – |
AQNU | ALGONQUIN PWR UTILS CORPunit 99/99/9999 | $6,651,000 | -2.4% | 140,800 | 0.0% | 0.08% | -5.6% | |
BRKS | New | AZENTA INC | $6,589,000 | – | 63,900 | +100.0% | 0.08% | – |
SHW | Sell | SHERWIN WILLIAMS CO | $6,515,000 | -11.8% | 18,500 | -29.9% | 0.08% | -14.4% |
AWK | AMERICAN WTR WKS CO INC NEW | $6,440,000 | +11.7% | 34,100 | 0.0% | 0.08% | +7.9% | |
KBH | KB HOME | $6,338,000 | +14.9% | 141,700 | 0.0% | 0.08% | +11.0% | |
ICPT | New | INTERCEPT PHARMACEUTICALS IN | $5,334,000 | – | 327,444 | +100.0% | 0.07% | – |
SBAC | Sell | SBA COMMUNICATIONS CORP NEWcl a | $5,135,000 | -34.7% | 13,200 | -44.5% | 0.07% | -36.5% |
FOUR | Buy | SHIFT4 PMTS INCcl a | $5,156,000 | +34.1% | 89,000 | +79.4% | 0.07% | +29.4% |
ARE | Sell | ALEXANDRIA REAL ESTATE EQ IN | $4,749,000 | -7.3% | 21,300 | -20.5% | 0.06% | -10.3% |
NEE | NEXTERA ENERGY INC | $4,472,000 | +18.9% | 47,900 | 0.0% | 0.06% | +14.0% | |
PHVS | PHARVARIS N V | $3,875,000 | -8.3% | 244,925 | 0.0% | 0.05% | -10.7% | |
SLAB | SILICON LABORATORIES INC | $3,950,000 | +47.3% | 19,137 | 0.0% | 0.05% | +42.9% | |
New | ARTERIS INC | $3,805,000 | – | 180,259 | +100.0% | 0.05% | – | |
EXACT SCIENCES CORPnote 0.375% 3/0 | $3,703,000 | -10.0% | 3,815,000 | 0.0% | 0.05% | -13.0% | ||
OM | Buy | OUTSET MED INC | $3,180,000 | -0.1% | 69,000 | +7.1% | 0.04% | -2.4% |
New | GUARDANT HEALTH INCnote 11/1 | $2,948,000 | – | 2,900,000 | +100.0% | 0.04% | – | |
KALV | Sell | KALVISTA PHARMACEUTICALS INC | $1,837,000 | -84.2% | 138,821 | -79.1% | 0.02% | -85.0% |
ETTX | ENTASIS THERAPEUTICS HLDGS I | $1,293,000 | -34.5% | 590,602 | 0.0% | 0.02% | -34.6% | |
New | PLANET LABS PBC | $953,000 | – | 155,000 | +100.0% | 0.01% | – | |
ALLK | Sell | ALLAKOS INC | $882,000 | -98.7% | 90,084 | -85.7% | 0.01% | -98.8% |
PLRX | Sell | PLIANT THERAPEUTICS INC | $574,000 | -98.4% | 42,499 | -98.1% | 0.01% | -98.6% |
DOCU | Exit | DOCUSIGN INC | $0 | – | -4,819 | -100.0% | -0.02% | – |
PATH | Exit | UIPATH INCcl a | $0 | – | -39,000 | -100.0% | -0.03% | – |
RPM | Exit | RPM INTL INC | $0 | – | -28,200 | -100.0% | -0.03% | – |
TMDX | Exit | TRANSMEDICS GROUP INC | $0 | – | -77,364 | -100.0% | -0.03% | – |
JKHY | Exit | HENRY JACK & ASSOC INC | $0 | – | -19,600 | -100.0% | -0.04% | – |
ZTS | Exit | ZOETIS INCcl a | $0 | – | -19,900 | -100.0% | -0.05% | – |
VFC | Exit | V F CORP | $0 | – | -77,300 | -100.0% | -0.07% | – |
FHN | Exit | FIRST HORIZON CORPORATION | $0 | – | -377,600 | -100.0% | -0.08% | – |
DCPH | Exit | DECIPHERA PHARMACEUTICALS IN | $0 | – | -400,000 | -100.0% | -0.18% | – |
ORIC | Exit | ORIC PHARMACEUTICALS INC | $0 | – | -724,972 | -100.0% | -0.20% | – |
BYND | Exit | BEYOND MEAT INC | $0 | – | -152,593 | -100.0% | -0.21% | – |
BFLY | Exit | BUTTERFLY NETWORK INC | $0 | – | -1,776,000 | -100.0% | -0.24% | – |
FIVN | Exit | FIVE9 INCcall | $0 | – | -108,800 | -100.0% | -0.26% | – |
SWKS | Exit | SKYWORKS SOLUTIONS INC | $0 | – | -150,047 | -100.0% | -0.33% | – |
ROL | Exit | ROLLINS INC | $0 | – | -727,500 | -100.0% | -0.34% | – |
LII | Exit | LENNOX INTL INC | $0 | – | -95,000 | -100.0% | -0.37% | – |
RNG | Exit | RINGCENTRAL INCcl a | $0 | – | -147,308 | -100.0% | -0.42% | – |
TPTX | Exit | TURNING POINT THERAPEUTICS I | $0 | – | -578,000 | -100.0% | -0.51% | – |
Exit | TRILLIUM THERAPEUTICS INC | $0 | – | -5,227,376 | -100.0% | -1.21% | – | |
TWLO | Exit | TWILIO INCcl a | $0 | – | -393,490 | -100.0% | -1.66% | – |
FVRR | Exit | FIVERR INTL LTD | $0 | – | -696,962 | -100.0% | -1.68% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-02-14
About Eventide Asset Management
Eventide Asset Management is a Boston-based investment firm that specializes in providing investment solutions to investors who are looking for long-term growth opportunities. The company was founded in 2008 by a group of experienced investment professionals who shared a common vision of creating a firm that would focus on investing in companies that are making a positive impact on society.
The company's investment philosophy is based on the belief that companies that are making a positive impact on society are more likely to be successful in the long run. Eventide's investment team conducts extensive research to identify companies that are aligned with this philosophy and have the potential to deliver strong returns over the long term.
The company's investment strategies are managed by a team of experienced professionals, including CEO Robin John, COO Finny Kuruvilla, and Chief Investment Officer, Dr. Finny Kuruvilla. The team has a proven track record of delivering strong returns to investors, and their investment strategies have been recognized by industry experts.
Eventide Asset Management offers a range of investment solutions, including mutual funds, separately managed accounts, and exchange-traded funds (ETFs). The company's funds are available to individual investors, financial advisors, and institutional investors.
Overall, Eventide Asset Management is a reputable investment firm that has a strong focus on investing in companies that are making a positive impact on society. The company's experienced investment team and proven track record make it a compelling option for investors who are looking for long-term growth opportunities.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
LOWES COS INC | 43 | Q2 2024 | 3.2% |
PALO ALTO NETWORKS INC | 43 | Q2 2024 | 3.6% |
ASML HOLDINGS NV | 43 | Q2 2024 | 1.9% |
REPLIGEN CORP | 43 | Q2 2024 | 0.5% |
VERACYTE INC | 41 | Q2 2024 | 1.5% |
NEUROCRINE BIOSCIENCES INC | 40 | Q3 2023 | 1.1% |
LAM RESEARCH CORP | 38 | Q2 2024 | 3.4% |
COLLEGIUM PHARMACEUTICAL INC | 37 | Q2 2024 | 2.6% |
BLUEPRINT MEDICINES CORP | 36 | Q2 2024 | 1.3% |
XPO LOGISTICS INC | 34 | Q1 2023 | 3.8% |
View Eventide Asset Management's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
908 Devices Inc. | February 14, 2024 | 1,430,995 | 4.4% |
Annexon, Inc.Sold out | February 14, 2024 | 0 | 0.0% |
Celldex Therapeutics, Inc. | February 14, 2024 | 3,630,013 | 6.6% |
COLLEGIUM PHARMACEUTICAL, INC | February 14, 2024 | 2,630,478 | 8.1% |
Freeline Therapeutics Holdings plcSold out | February 14, 2024 | 0 | 0.0% |
Inozyme Pharma, Inc. | February 14, 2024 | 3,179,837 | 5.2% |
Korro Bio, Inc. | February 14, 2024 | 546,325 | 6.8% |
MARINUS PHARMACEUTICALS, INC. | February 14, 2024 | 4,529,997 | 8.3% |
Mirum Pharmaceuticals, Inc. | February 14, 2024 | 2,693,581 | 5.8% |
Praxis Precision Medicines, Inc.Sold out | February 14, 2024 | 0 | 0.0% |
View Eventide Asset Management's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
N-PX | 2024-08-27 |
13F-HR | 2024-08-13 |
SC 13G/A | 2024-08-09 |
13F-HR | 2024-05-15 |
13F-HR/A | 2024-02-20 |
13F-HR | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
View Eventide Asset Management's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.